Over-the-counter nicotine replacement therapy: a methodological review of the evidence supporting its effectiveness

References

• Silagy C, Lancaster T, Stead L, Mant D, Fowler G. Nicotine replacement therapy for smoking cessation (Cochrane Review). John Wiley & Sons Ltd, Chichester, UK, The Cochrane Library, Issue 3, 2004
   Google Scholar
• Shiffman S, Gitchell J, Pinney J M, Burton S L, Kemper K E, Lara E O. Public health benefit of over-the-counter nicotine medications. Tob Control 1997; 6: 306–310
   PubMedGoogle Scholar
• Paul C L, Walsh R A, Girgis A. Nicotine replacement therapy products over the counter: real-life use in the Australian community. Aust NZ J Public Health 2003; 27: 491–495
   PubMed Web of Science ®Google Scholar
• Buck D, Morgan A. Smoking and quitting with the aid of nicotine replacement therapies in the English adult population: results from the Health Education Monitoring Survey 1995. Eur J Public Health 2001; 11: 211–217
   PubMed Web of Science ®Google Scholar
• Cummings K M, Hyland A. Impact of nicotine replacement therapy on smoking behaviour. Annu Rev Public Health 2005; 26: 583–599
   PubMed Web of Science ®Google Scholar
• Fiore M C, Bailey W C, Cohen S J, et al. Treating tobacco use and dependence. Clinical practice guideline. US Department of Health and Human Services, Public Health Service, Rockville, MD 2000
   Google Scholar
• Keeler T E, Hu T, Kerth A, et al. The benefits of switching smoking cessation drugs to over-the-counter status. Health Econ 2002; 11: 389–402
   PubMed Web of Science ®Google Scholar
• Fiscella K, Franks P. Use of over-the-counter nicotine patch for smoking cessation: prudent or premature. JAMA 1996; 276: 371–372
   PubMed Web of Science ®Google Scholar
• Walsh R A, Penman A G. The effectiveness of nicotine replacement therapy over-the-counter. Drug Alcohol Rev 2000; 19: 243–247
   Web of Science ®Google Scholar
• Thorndike A N, Brener L, Rigotti N A. Effect on smoking cessation of switching nicotine replacement therapy to over-the-counter status. Am J Public Health 2002; 92: 437–442
   PubMed Web of Science ®Google Scholar
• Pierce J P, Gilpin E A. Impact of over-the-counter sales on effectiveness of pharmaceutical aids for smoking cessation. JAMA 2002; 288: 1260–1264
   PubMed Web of Science ®Google Scholar
• Burton S L, Kemper K E, Baxter T A, Shiffman S, Gitchell J, Currence C. Impact of promotion of the Great American Smokeout and availability of over-the-counter nicotine medications. JAMA 1997; 278: 2055–2056
   PubMed Web of Science ®Google Scholar
• Alberg A J, Patnaik J, May J W, et al. Nicotine replacement therapy use among a cohort of smokers. J Addict Dis 2005; 24: 101–113
   PubMed Web of Science ®Google Scholar
• Stead L F, Davis R M, Fiore M C, Hatsukami D K, Raw M, West R. Effectiveness of over-the-counter nicotine replacement therapy. JAMA 2002; 288: 3109–3110
   PubMed Web of Science ®Google Scholar
• Zhu S-H, Melcer T, Sun J, Rosbrook B, Pierce J P. Smoking cessation with and without assistance: a population-based analysis. Am J Prev Med 2000; 18: 305–311
   PubMed Web of Science ®Google Scholar
• Shiffman S, Di Marino M E, Sweeney C T. Characteristics of selectors of nicotine replacement therapy. Tob Control 2005; 14: 346–355
   PubMed Web of Science ®Google Scholar
• Gilpin E, Pierce J P. Measuring smoking cessation: problems with recall in the 1990 California Tobacco Survey. Cancer Epidemiol Biomarkers Prev 1994; 3: 613–617
   PubMed Web of Science ®Google Scholar
• Reed M B, Anderson C M, Vaughn J W, Burns D M. The effect of over-the-counter sales of nicotine patch and nicotine gum on smoking cessation in California. Cancer Epidemiol Biomarkers Prev 2005; 14: 2131–2136
   PubMed Web of Science ®Google Scholar
• West R. Effects on smoking cessation of a national strategy to maximise NRT usage: the UK experience (Abstract 141–2). 13th World Conference on Tobacco or Health, 12–15 July 2006. Library of Abstracts CD. American Cancer Society, Washington, DC 2006
   Google Scholar
• Hyland A, Revaishiraz H, Giovino G, Bauer J E, Cummings K M. Over the counter availability of nicotine replacement therapy and smoking cessation. Nicotine Tob Res 2005; 7: 547–555
   PubMed Web of Science ®Google Scholar
• Foulds J, Steinberg M B, Williams J M, Ziedonis D M. Developments in pharmacotherapy for tobacco dependence: past, present and future. Drug Alcohol Rev 2006; 25: 59–71
   PubMed Web of Science ®Google Scholar
• Biener L, Reimer R L, Wakefield M, Szczypka G, Rigotti N A, Connolly G. Impact of smoking cessation aids and mass media among recent quitters. Am J Prev Med 2006; 30: 217–224
   PubMed Web of Science ®Google Scholar
• Al-Delaimy W K, Gilpin E A, Pierce J P. When Californian smokers use nicotine replacement therapy, most are trying to quit smoking. Tob Control 2005; 14: 359–360
   PubMed Web of Science ®Google Scholar
• Hughes J R, Shiffman S, Callas P, Zhang J. A meta-analysis of the efficacy of over-the-counter nicotine replacement therapy. Tob Control 2003; 12: 21–27
   PubMed Web of Science ®Google Scholar
• Higgins J PT, Thompson S G, Deeks J J, Altman D G. Measuring inconsistency in meta-analysis. BMJ 2003; 327: 557–560
   PubMed Web of Science ®Google Scholar
• Jadad A R, Moher M, Browman G P, et al. Systematic reviews and meta-analyses on treatment of asthma: critical evaluation. BMJ 2000; 320: 537–540
   PubMed Web of Science ®Google Scholar
• Moher D, Schulz K F, Altman D G, for the Consort Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001; 357: 1191–1194
   PubMed Web of Science ®Google Scholar
• Moher D, Cook D J, Eastwood S, Olkin I, Rennie D, Stroup D F. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of reporting of meta-analyses. Lancet 1999; 354: 1896–1900
   PubMed Web of Science ®Google Scholar
• Peck R C. Inherent problems with meta-analysis. Addiction 1995; 90: 1589–1591
   PubMed Web of Science ®Google Scholar
• Altman D G, Schulz K F, Moher D, et al. The Revised CONSORT Statement for reporting randomised trials: explanation and elaboration. Ann Intern Med 2001; 134: 663–694
   PubMed Web of Science ®Google Scholar
• Khan K S, ter Riet G, Glauville J, Sowden A J, Kleijnen J. Undertaking systematic reviews of research on effectiveness: CRD's guidance for those carrying out or commissioning reviews, 2nd edn. University of York: NHS Centre for Reviews and Dissemination. 2001, CRD Report no. 4
   Google Scholar
• Schneider N G, Jarvik M E, Forsythe A B, Read L L, Elliott M L, Schweiger A. Nicotine gum in smoking cessation: a placebo-controlled, double-blind trial. Addict Behav 1983; 8: 253–261
   PubMed Web of Science ®Google Scholar
• Sønderskov J, Olsen J, Sabroe S, Meillier L, Overvad K. Nicotine patches in smoking cessation: a randomised trial among over-the-counter customers in Denmark. Am J Epidemiol 1997; 145: 309–318
   PubMed Web of Science ®Google Scholar
• Hays J T, Croghan I T, Schroeder D R, et al. Over-the-counter nicotine patch therapy for smoking cessation: results from randomised, double-blind, placebo-controlled, and open label trials. Am J Public Health 1999; 89: 1701–1707
   PubMed Web of Science ®Google Scholar
• Davidson M, Epstein M, Burt R, Schaefer C, Whitworth G, McDonald A. Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation. Arch Fam Med 1998; 7: 569–574
   PubMedGoogle Scholar
• Leischow S J, Muramoto M L, Cook G N, Merikle E P, Castellini S M, Otte P S. OTC nicotine patch: effectiveness alone and with brief physician intervention. Am J Health Behav 1999; 23: 61–69
   Web of Science ®Google Scholar
• Shiffman S, Rolf C N, Hellebusch S J, et al. Real-world efficacy of prescription and over-the-counter nicotine replacement therapy. Addiction 2002; 97: 505–516
   PubMed Web of Science ®Google Scholar
• Shiffman S, Gorsline J, Gorodetzky C W. Efficacy of over-the-counter nicotine patch. Nicotine Tob Res 2002; 4: 477–483
   PubMedGoogle Scholar
• Leischow S J, Ranger-Moore J, Muramoto M L, Matthews E. Effectiveness of the nicotine inhaler for smoking cessation in an OTC setting. Am J Health Behav 2004; 28: 291–301
   PubMed Web of Science ®Google Scholar
• Killen J D, Fortmann S P, Newman B, Varady A. Evaluation of a treatment approach combining nicotine gum with self-guided behavioural treatments for smoking relapse prevention. J Consult Clin Psychol 1990; 58: 85–92
   PubMed Web of Science ®Google Scholar
• Fortmann S P, Killen J D. Nicotine gum and self-help behavioural treatment for smoking relapse prevention: results from a trial using population-based recruitment. J Consult Clin Psychol 1995; 63: 460–468
   PubMed Web of Science ®Google Scholar
• Killen J D, Fortmann S P, Davis L, Varady A. Nicotine patch and self-help video for cigarette smoking cessation. J Consult Clin Psychol 1997; 65: 663–672
   PubMed Web of Science ®Google Scholar
• Shiffman S, Dresler C M, Hajek P, Gilburt S JA, Targett D A, Strahs K R. Efficacy of a nicotine lozenge for smoking cessation. Arch Intern Med 2002; 162: 1267–1276
   PubMed Web of Science ®Google Scholar
• Shiffman S, Dresler C M, Rohay J M. Successful treatment with a nicotine lozenge of smokers with prior failure in pharmacological therapy. Addiction 2004; 99: 83–92
   PubMed Web of Science ®Google Scholar
• Winchell C J, Wright C, Burke L, Kramer E D, Longmire A W, Scheinbaum M L. Long-term abstinence in users of OTC nicotine replacement. Clin Pharmacol Ther 1997; 81: 191
   Google Scholar
• Korberly B H, Maguire M K, An open label multicenter trial to evaluate and compare the efficacy of Hicotrol 15mg as part of an OTC intervention package or as a prescription as an aid in smoking cessation. Society for Research on Nicotine and Tobacco, San Diego, CA, 5–7 March 1999
   Google Scholar
• Cummings K M, Hyland A, Ockene J K, Hymowitz N, Manley M. Use of nicotine skin patches by smokers in 20 communities in the United States, 1992–1993. Tob Control 1997; 6: 563–570
   Google Scholar
• Miller C, Kriven S, Rowley D, Abram L. Be wary of subsidising nicotine replacement therapy. Tob Control 2002; 11: 380–381
   PubMed Web of Science ®Google Scholar
• Boyle R G, Solberg L I, Magnan S, Davidson G, Alesci N L. Does insurance coverage for drug therapy affect smoking cessation. Health Affairs 2002; 21: 162–168
   PubMed Web of Science ®Google Scholar
• Alberg A J, Margalit R S, Burke A, et al. The influence of offering free transdermal nicotine patches on quit rates in a local health department's smoking cessation program. Addict Behav 2004; 29: 1763–1778
   PubMed Web of Science ®Google Scholar
• Miller N, Frieden T R, Liu S Y, et al. Effectiveness of a large-scale distribution programme of free nicotine patches: a prospective evaluation. Lancet 2005; 365: 1849–1854
   PubMed Web of Science ®Google Scholar
• Fiore M C, Thompson S A, Lawrence D L, et al. Helping Wisconsin women quit smoking: a successful collaboration. Wisconsin Med J 2000; 99: 68–72
   Google Scholar
• Grigg M, Glasgow H. Subsidised nicotine replacement therapy. Tob Control 2003; 12: 238–239
   PubMed Web of Science ®Google Scholar
• McDonald P W. Population-based recruitment for quit-smoking programs: an analytic review of communication variables. Prev Med 1999; 28: 545–557
   PubMed Web of Science ®Google Scholar
• Kottke T E, Battista R N, DeFriese G H, Brekke M L. Attributes of successful smoking cessation interventions in medical practice: a meta-analysis of 39 controlled trials. JAMA 1988; 259: 2883–2889
   PubMed Web of Science ®Google Scholar
• Murray R P, Anthonisen N R. Interventions for smoking cessation: the outcomes are determined by the questions asked. Eur Resp J 1999; 13: 231–232
   PubMed Web of Science ®Google Scholar
• Walsh R A. The Cochrane review on nicotine replacement therapy: incorrect or uncertain classifications of additional support levels. Tob Control 2007; 16: 215–216
   PubMed Web of Science ®Google Scholar
• Stead L, Lancaster T. Authors' response. Tob Control 2007; 16: 216
   Google Scholar
• Schwartz J L. Review and evaluation of smoking cessation methods: the United States and Canada, 1978–1985. NIH Publication no. 87–2940. US Department of Health and Human Services, Public Health Service, National Institutes of Health, Bethesda, MD 1987
   Google Scholar
• Mattick R P, Baillie A. An outline for approaches to smoking cessation. Quality assurance in the treatment of drug dependence project. Australian Government Publishing Service, Canberra 1992, National Campaign Against Drug Abuse Monograph Series no. 19
   Google Scholar
• Mooney M, Babb D, Jensen J, Hatsukami D. Interventions to increase use of nicotine gum: a randomised, controlled, single-blind trial. Nicotine Tob Res 2005; 7: 565–579
   PubMed Web of Science ®Google Scholar
• Blum A. Nicotine chewing gum and the medicalization of smoking. Ann Intern Med 1984; 101: 121–123
   PubMed Web of Science ®Google Scholar
• Velicer W F, Fava J L, Keller S, et al. Evaluating nicotine replacement therapy and stage-based therapies in a population-based effectiveness trial. J Consult Clin Psychol 2006; 74: 1162–1172
   PubMed Web of Science ®Google Scholar
• Mooney M, White T, Hatsukami D. The blind spot in the nicotine replacement therapy literature: assessment of the double-blind in clinical trials. Addict Behav 2004; 29: 673–684
   PubMed Web of Science ®Google Scholar
• Hughes J R, Krahn D. Blindness and the validity of the double-blind procedure. J Clin Pharmacol 1985; 5: 138–142
   Google Scholar
• Dar R, Stronguin F, Etter J-F. Assigned versus perceived placebo effects in nicotine replacement therapy for smoking reduction in Swiss smokers. J Consult Clin Psychol 2005; 73: 350–353
   PubMed Web of Science ®Google Scholar
• Australian Institute of Health and Welfare (AIHW). 2004 National Drug Strategy Household Survey: First results. AIHW, Canberra 2005, AIHW Cat. no. PHE57. Drug Statistics Series no.13
   Google Scholar
• Maurice E, Trosclair A, Merritt R, Caraball R, Malarcher A, Pechacek T. Cigarette smoking among adults—United States 2004. MMWR 2005; 54: 1121–1124
   PubMedGoogle Scholar
• West R, Hajek P, Stead L, Stapleton J. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005; 100: 299–303
   PubMed Web of Science ®Google Scholar
• Velicer W F, Prochaska J O, Rossi J S, Snow M G. Assessing outcome in smoking cessation studies. Psychol Bull 1992; 111: 23–41
   PubMed Web of Science ®Google Scholar
• Hughes J R, Keely J P, Niaura R S, Ossip-Klein D J, Richmond R L, Swan G E. Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res 2003; 5: 13–25
   PubMed Web of Science ®Google Scholar
• Keely J P, Hughes J R, Carpenter M J. A method to convert prolonged abstinence and point prevalence quit rates In: Wetter D. Breaking down boundaries in nicotine and tobacco research. Nicotine Tob Res 2001; 3: 272–273
   Google Scholar
• Velicer W F, Prochaska J O. A comparison of four self-report smoking cessation outcome measures. Addict Behav 2004; 29: 51–60
   PubMed Web of Science ®Google Scholar
• Kjaergard L L, Als-Nielsen B. Association between competing interests and authors' conclusions: epidemiological study of randomised clinical trials published in the BMJ. BMJ 2002; 23: 249–252
   Web of Science ®Google Scholar
• Lexchin J, Bero L A, Djulbegovic B, Clark O. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 2003; 326: 1167–1170
   PubMed Web of Science ®Google Scholar
• Kaptchuk T J. Effect of interpretive bias on research evidence. BMJ 2003; 326: 1453–1455
   PubMed Web of Science ®Google Scholar
• Etter J-F, Burri M, Stapleton J. The impact of pharmaceutical company funding on results of randomised trials of nicotine replacement therapy for smoking cessation: a meta-analysis. Addiction 2007; 102: 815–822
   PubMed Web of Science ®Google Scholar
• Fagerström K O. Clinical treatment of tobacco dependence: the endurance of pharmacologic efficacy. J Clin Psychiatr Monogr 2003; 18: 35–40
   Google Scholar
• Medioni J, Berlin I, Mallet A. Increase risk of relapse after stopping nicotine replacement therapies: a mathematical modelling approach. Addiction 2005; 100: 247–254
   PubMed Web of Science ®Google Scholar
• Berlin J A, Rennie D. Measuring the quality of trials. The quality of quality scales. JAMA 1999; 282: 1083–1085
   PubMed Web of Science ®Google Scholar
• Balk E M, Bonis P AL, Moskowitz H, et al. Correlation of quality measures with estimates of treatment effect in meta-analyses of randomised controlled trials. JAMA 2002; 287: 2973–2982
   PubMed Web of Science ®Google Scholar
• Hughes J R, Gulliver S B, Fenwick J W, et al. Smoking cessation among self-quitters. Health Psychol 1992; 11: 331–334
   PubMed Web of Science ®Google Scholar
• Marlatt G A, Curry S, Gordon J R. A longitudinal analysis of unaided smoking cessation. J Consult Clin Psychol 1988; 56: 715–720
   PubMed Web of Science ®Google Scholar
• Cohen S, Lichtenstein E, Prochaska J O, et al. Debunking myths about self-quitting: evidence from 10 prospective studies of persons who attempt to quit smoking by themselves. Am Psychol 1989; 44: 1355–1365
   PubMed Web of Science ®Google Scholar
• Garvey A J, Bliss R E, Hitchcock J L, Heinold J W, Rosner B. Predictors of smoking relapse among self-quitters: a report from the Normative Aging Study. Addict Behav 1992; 17: 367–377
   PubMed Web of Science ®Google Scholar
• Carey M P, Kalra D L, Carey K B, Halperin S, Richards C S. Stress and unaided smoking cessation: a prospective investigation. J Consult Clin Psychol 1993; 61: 831–838
   PubMed Web of Science ®Google Scholar
• Baillie A J, Mattick R P, Hall W. Quitting smoking: estimation by meta-analysis of the rate of unaided smoking cessation. Aust J Public Health 1995; 19: 129–131
   PubMedGoogle Scholar
• Irvin J E, Hendricks P S, Brandon T H. The increasing recalcitrance of smokers in clinical trials II: Pharmacotherapy trials. Nicotine Tob Res 2003; 5: 27–35
   PubMed Web of Science ®Google Scholar
• Hyland A, Li Q, Bauer J E, Giovino G A, Steger C, Cummings K M. Predictors of cessation in a cohort of current and former smokers followed over 13 years. Nicotine Tob Res 2004; 6: S363–S369
   PubMed Web of Science ®Google Scholar
• Lindstrom M, Isacsson S-O. The Malmo Shoulder–Neck Study Group. Smoking cessation among daily smokers, aged 45–69 years: a longitudinal study in Malmo, Sweden. Addiction 2002; 97: 205–215
   PubMed Web of Science ®Google Scholar
• Hughes J R, Keely J, Naud S. Shape of the relapse curve and long-term abstinence among untreated smokers. Addiction 2004; 99: 29–38
   PubMed Web of Science ®Google Scholar
• Etter J-F, Stapleton J A. Nicotine replacement therapy for long-term smoking cessation: a meta-analysis. Tob Control 2006; 15: 280–285
   PubMed Web of Science ®Google Scholar
• Lawrence C A, Schillo B A, Kavanaugh R B, et al. Increased reach and effectiveness of a statewide tobacco quitline after the addition of access to free nicotine replacement therapy. Tob Control 2006; 15: 286–293
   PubMed Web of Science ®Google Scholar